Impact of antiviral AV2 in the topical treatment of HPV-associated lesions of the cervix: Results of a phase III randomized placebo-controlled trial.

ABSTRACT:

Background

Non-surgical topical therapies have been assessed in the treatment of precancerous lesions of the cervix. Their use can offer logistical and feasibility advantages in low-resource settings. Antiviral AV2^® is a mixture of natural essential oils (eugenol, carvone, nerolidol, geraniol) in olive oil, and has a broad spectrum anti-viral activity. In a phase II randomized controlled trial (RCT), AV2^® proved effective in reducing the size of cervical lesions associated with human papillomavirus (HPV). The purpose of the present study was to further evaluate the efficacy of AV2 over placebo in the topical treatment of HPV-associated cervical lesions.

Methods

Women aged 25 years and older were included in this phase 3 RCT. Cytology screening, HPV test

SUBMITTER: Baleka Mutombo A 

PROVIDER: S-EPMC6529824 | biostudies-literature | 2019 Sep

REPOSITORIES: biostudies-literature